For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in ...

A new international study has offered hope that Alzheimer’s disease may one day be preventable—at least in people genetically ...

AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

Eli Lilly stock has generated fantastic returns ... However, there's also hope that Alzheimer's drug Kisunla, which regulators approved last year, may also become a blockbuster for the business.

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...